Business brief
Mega-Mergers and Post-Prime Realignment
Skydance seals its $81B studio combination while retail giants and utility champions prune costs and expand balance sheets.
Business
Skydance absorbed Warner Bros. Discovery for $81B — creating an entertainment juggernaut to survive the streaming war against tech giants.
BackgroundLegacy entertainment companies have suffered falling cable television subscriber revenues and prolonged streaming profitability losses against tech competitors like Netflix and Apple. Skydance launched an ambitious bid to unite two of Hollywood's oldest film lots under private family control.
- U.S. District Judge Araceli Martínez-Olguín approved the consent decree resolving antitrust litigation filed by 12 state attorneys general, eliminating the last regulatory obstacle to integration.
- Warner Bros. Discovery stock was suspended from trading on the Nasdaq as equity conversions into merged Skydance shares took effect, concluding the company's run as an independent entity.
- The consolidated media giant controls DC Comics, HBO, CNN, and Paramount Pictures alongside deep linear television broadcast assets, giving the combined firm massive intellectual property scale.
Business
Amazon trimmed 1,000 corporate retail positions right after Prime Day — funding heavy AI infrastructure bets by tightening retail headcounts.
BackgroundAmazon's Stores business manages the company's flagship retail marketplace, seller support systems, and third-party merchant logistics networks. The e-commerce giant has repeatedly pruned administrative headcounts across commercial divisions while ramping multi-billion-dollar datacenter capital expenditure.
- Layoffs affected operational management, seller onboarding, and customer services across Seattle, London, and Indian regional hubs, leaving surviving teams to handle automated merchant workflows.
- Company spokespeople confirmed the cuts, citing strategic reorganizations designed to improve operating execution across core retail divisions as corporate spending concentrates on artificial intelligence.
- Financial analysts noted retail cost cuts help fund Amazon's surging capital investments in datacenter infrastructure and custom silicon, signaling tighter operational budgets for non-cloud divisions.
Business
Applied Digital quadrupled quarterly revenue on AI data hosting — turning scarce energized power connections into $36B in long-term contracts.
BackgroundApplied Digital transitioned from cryptocurrency mining hosting toward building high-density artificial intelligence computing campuses leased to enterprise hyperscalers. Securing grid power interconnects and high-voltage electrical equipment has made datacenter infrastructure providers highly sought after.
- High-performance compute hosting generated $262.6M in quarterly revenue, supported by tenant fit-out services and contracted facility rents from major enterprise artificial intelligence clients.
- Adjusted EBITDA reached $64.4M compared to $0.5M a year ago, reflecting strong operating leverage on energized capacity as newly built capacity came online.
- Management confirmed long-term contracted pipeline revenue reached approximately $36B across 5 regional computing campuses, cementing long-term demand visibility from hyperscale cloud operators.
Business
Biohaven monetized Asian rights for $100M — funding American Phase 3 trials without dilution while locking in 20% commercial royalties.
BackgroundExtracellular immunoglobulin G degraders are an emerging class of biotech therapies designed to treat autoimmune conditions by removing harmful circulating antibodies. Biohaven advanced its lead candidate BHV-1300 into Phase 3 trials for Graves' disease while retaining full commercial rights in Western markets.
- Ono Pharmaceutical will pay $80M in upfront cash followed by a $20M development milestone to develop 3 therapy candidates across designated Asian markets.
- Biohaven secured a 20% tiered royalty rate on net commercial sales across Japan and ASEAN territories upon regulatory approvals, establishing recurring cash flow streams.
- Capital proceeds will fund Biohaven's late-stage clinical programs in the United States and Europe without diluting existing shareholders through new equity offerings.
Business
Business
Business
Business
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
